All lobbying filings
EMD MILLIPORE CORPORATION
Lobbying for EMD MILLIPORE CORPORATION · Manufacturing of preparation, separation, filtration and monitoring life sciences tools.
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$100,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Government bodies contacted
4
Lobbying activity
2
Section 301 Tariffs - Discussions related to the impact of Reciprocal Tariffs on U.S. biomanufacturing Section 232 Tariffs - Discussions related to the impact of Pharmaceutical Tariffs on U.S. biomanufacturing
General discussions related to federal procurement policy